Making Investments Now for Dementia Act of 2013
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
29pct
1d open
vs 5,821 other HR bills in the 113th — cohort avg 49d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2014 · fourth_quarter · Medical/Disease Research/Clinical Labs
H.R. 1619 Making Investments Now for Dementia Act, All sections H.R. 3681 Accelerating Innovation in Medicine (the AIM Act) S. 2115 - American Cures Act H.R. 1508/S.1091 - To provide for the issuance of an Alzheimer's Disease Research Semipostal stamp, All sections H.R. 5580/S. 2658 - Accelerating Biomedical Research Act
Client expense: $136,000 · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2014 · third_quarter · Medical/Disease Research/Clinical Labs
H.R. 1619 Making Investments Now for Dementia Act, All sections H.R. 3681 Accelerating Innovation in Medicine (the AIM Act) S. 2115 - American Cures Act H.R. 1508/S.1091 - To provide for the issuance of an Alzheimer's Disease Research Semipostal stamp, All sections H.R.1508/S.1091 - To provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp, All Sections
Client expense: $136,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2014 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 1619 Making Investments Now for Dementia Act, All sections H.R. 3681 Accelerating Innovation in Medicine (the AIM Act) S. 2115 - American Cures Act H.R. 1508/S.1091 - To provide for the issuance of an Alzheimer's Disease Research Semipostal stamp, All sectionsH.R.1508/S.1091 - To provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp, All Sections
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2014 · first_quarter · Medical/Disease Research/Clinical Labs
H.R. 1619 Making Investments Now for Dementia Act, All sections H.R. 3681 Accelerating Innovation in Medicine (the AIM Act) S. 2115 - American Cures Act H.R. 1508/S.1091 - To provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp, All Sections
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2013 · fourth_quarter · Medical/Disease Research/Clinical Labs
Alzheimer's Breakthrough Act, All sections H.R. 1619 Making Investments Now for Dementia Act, All sections H.R. 3681 Accelerating Innovation in Medicine (the AIM Act)H.R.1508/S.1091 - To provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp, All Sections
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2013 · third_quarter · Medical/Disease Research/Clinical Labs
Alzheimer's Breakthrough Act, All sections H.R. 1619 Making Investments Now for Dementia Act, All sectionsH.R.1508/S.1091 - To provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp, All Sections
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2013 · second_quarter · Medical/Disease Research/Clinical Labs
Alzheimer's Breakthrough Act, All sections H.R. 1619 Making Investments Now for Dementia Act, All sectionsH.R.1508/S.1091 - To provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp, All Sections
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2013 · second_quarter · Health Issues
Support for the preservation and expansion of the graduate medical education funding; Support for more research funds for Alzheimers Disease and other dementias including NIH appropriations and private funding models as outlined in HR 1619, the Making Investments Now for Dementia (MIND) Act of 2013; Support for improved concussion safety standards for youth athletics including supporting HR 2118 / S 1014, the Youth Sports Concussion Act of 2013;Support for the expanded and appropriate use of telemedicine; Support S 1027 to improve, coordinate, and enhance rehabilitation research at the NIH; Support the reduction/elimination of specialty tiers within private health plans including supporting HR 460, Patients' Access to Treatments Act of 2013; Support for credential disclosure by health care providers in HR 1427, the Truth in Health Marketing Act of 2013; Opposing automatic sequestration cuts to NIH research; Submitted recommendations to the FDA on the proposed guidance document on Alzheimers disease research; Submitted recommendations to the Assistant Secretary of Planning and Evaluation on what topics should be included in measuring physicians time and work.
Client expense: $320,000 · Firm income: Not reported
| Republican |
| TX |
| Keith Ellison | Democratic | MN |
| Kenny Marchant | Republican | TX |
| Michael G. Fitzpatrick | Republican | PA |
| Peter J. Roskam | Republican | IL |
| Peter T. King | Republican | NY |
| Steve Israel | Democratic | NY |
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), SENATE